Sana Biotechnology (SANA)
(Delayed Data from NSDQ)
$3.09 USD
-0.20 (-6.08%)
Updated Sep 19, 2025 04:00 PM ET
After-Market: $3.11 +0.02 (0.65%) 7:58 PM ET
3-Hold of 5 3
F Value A Growth C Momentum C VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
SANA 3.09 -0.20(-6.08%)
Will SANA be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for SANA based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for SANA
SANA Gears Up to Report Q4 Earnings: What's in the Cards?
SANA Stock Surges 152% in a Week on Upbeat Initial Diabetes Study Data
SANA: What are Zacks experts saying now?
Zacks Private Portfolio Services
Here's Why Sana (SANA) Could be Great Choice for a Bottom Fisher
Down -24.69% in 4 Weeks, Here's Why Sana (SANA) Looks Ripe for a Turnaround
Other News for SANA
Fell Below 20 Day Moving Average appears for SANA after 6.08% move
SANA Crossed Above 20 Day Moving Average on September 18
Is SANA setting up for a drop? 20 Day Moving Average Resistance shows up after slipping 1.94%
H.C. Wainwright Sticks to Their Buy Rating for Sana Biotechnology (SANA)
Is SANA primed for downward momentum? Fell Below 20 Day Moving Average shows up after sinking 4.02%